![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif)
mixed bacteria vaccine A cancer vaccine containing a mixture of killed bacteria with potential immunostimulatory and antineoplastic activities. Mixed bacteria vaccine (MBV or Coley’s toxins) consists of a pyrogenic bacterial lysate derived from Serratia marcescens and Streptococcus pyogenes; the active components in the lysate may be lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell wall of Serratia, and streptokinase, an enzyme produced by Streptococcus pyogenes. LPS has been shown to stimulate the host humoral immune response and induce the release of various antitumor cytokines such as tumor necrosis factor (TNF) and interleukin-12 (IL-12). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) | Coley's toxins | | ![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) | Acronym: | ![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) | MBV | | ![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090509155828im_/http://www.cancer.gov/images/spacer.gif) |